These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 21600519)

  • 1. Effects of lecithin: cholesterol acyltransferase genotypes, enzyme levels, and activity on high-density lipoprotein levels.
    Agirbasli D; Cirakoglu B; Eren F; Sumerkan M; Aksoy S; Aral C; Agirbasli M
    J Clin Lipidol; 2011; 5(3):152-158. PubMed ID: 21600519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Lecithin Cholesterol Acyltransferase rs5923 Polymorphism in Iranian Individuals with Extremely Low High-Density Lipoprotein Cholesterol: Tehran Lipid and Glucose Study.
    Naseri M; Hedayati M; Daneshpour MS; Bandarian F; Azizi F
    Iran Biomed J; 2015; 19(3):172-6. PubMed ID: 26117245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on the association of lecithin cholesterol acyltransferase gene polymorphisms with the lipid metabolism in coronary atherosclerotic heart disease].
    Zhang K; Zhang S; Zheng K; He Y; Zhang L; Su Z; Sun Y; Shi J; Kong X; Tong Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):135-7. PubMed ID: 12673583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lecithin-cholesterol acyltransferase gene 608C/T polymorphism associated with atherosclerotic cerebral infarction].
    Zhu XY; Xu HW; Hou RY; Liu HF; Xiao B; Yang XS; Yang QD; Tang BS
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Aug; 23(4):419-22. PubMed ID: 16883530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High plasma lecithin:cholesterol acyltransferase activity does not predict low incidence of cardiovascular events: possible attenuation of cardioprotection associated with high HDL cholesterol.
    Dullaart RP; Perton F; van der Klauw MM; Hillege HL; Sluiter WJ;
    Atherosclerosis; 2010 Feb; 208(2):537-42. PubMed ID: 19698944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of genetic variants of lecithin cholesterol acyltransferase in individuals with high HDL‑C levels.
    Naseri M; Hedayati M; Daneshpour MS; Bandarian F; Azizi F
    Mol Med Rep; 2014 Jul; 10(1):496-502. PubMed ID: 24789697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A DNA polymorphism for LCAT is associated with altered LCAT activity and high density lipoprotein size distributions in baboons.
    Rainwater DL; Blangero J; Hixson JE; Birnbaum S; Mott GE; VandeBerg JL
    Arterioscler Thromb; 1992 Jun; 12(6):682-90. PubMed ID: 1350465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review on lecithin:cholesterol acyltransferase deficiency.
    Saeedi R; Li M; Frohlich J
    Clin Biochem; 2015 May; 48(7-8):472-5. PubMed ID: 25172171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetic study of Finns with hypoalphalipoproteinemia and hyperalphalipoproteinemia: a novel Gly230 Arg mutation (LCAT[Fin]) of lecithin:cholesterol acyltransferase (LCAT) accounts for 5% of cases with very low serum HDL cholesterol levels.
    Miettinen HE; Gylling H; Tenhunen J; Virtamo J; Jauhiainen M; Huttunen JK; Kantola I; Miettinen TA; Kontula K
    Arterioscler Thromb Vasc Biol; 1998 Apr; 18(4):591-8. PubMed ID: 9555865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of hepatic lecithin:cholesterol acyltransferase gene expression in chronic renal failure.
    Vaziri ND; Liang K; Parks JS
    Kidney Int; 2001 Jun; 59(6):2192-6. PubMed ID: 11380821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired lecithin:cholesterol acyltransferase deficiency as a major factor in lowering plasma HDL levels in chronic kidney disease.
    Calabresi L; Simonelli S; Conca P; Busnach G; Cabibbe M; Gesualdo L; Gigante M; Penco S; Veglia F; Franceschini G
    J Intern Med; 2015 May; 277(5):552-61. PubMed ID: 25039266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lecithin:cholesterol acyltransferase (LCAT) mass; its relationship to LCAT activity and cholesterol esterification rate.
    Albers JJ; Chen CH; Adolphson JL
    J Lipid Res; 1981 Nov; 22(8):1206-13. PubMed ID: 7320631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A DNA polymorphism for lecithin:cholesterol acyltransferase (LCAT) is associated with high density lipoprotein cholesterol concentrations in baboons.
    Kammerer CM; Hixson JE; Mott GE
    Atherosclerosis; 1993 Jan; 98(2):153-63. PubMed ID: 8457258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis.
    Hoeg JM; Santamarina-Fojo S; Bérard AM; Cornhill JF; Herderick EE; Feldman SH; Haudenschild CC; Vaisman BL; Hoyt RF; Demosky SJ; Kauffman RD; Hazel CM; Marcovina SM; Brewer HB
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11448-53. PubMed ID: 8876155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and functional analysis of missense mutations in the lecithin cholesterol acyltransferase gene in a Chilean patient with hypoalphalipoproteinemia.
    Tobar HE; Cataldo LR; González T; Rodríguez R; Serrano V; Arteaga A; Álvarez-Mercado A; Lagos CF; Vicuña L; Miranda JP; Pereira A; Bravo C; Aguilera CM; Eyheramendy S; Uauy R; Martínez Á; Gil Á; Francone O; Rigotti A; Santos JL
    Lipids Health Dis; 2019 Jun; 18(1):132. PubMed ID: 31164121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma lecithin: cholesterol acyltransferase activity modifies the inverse relationship of C-reactive protein with HDL cholesterol in nondiabetic men.
    Dullaart RP; Perton F; Kappelle PJ; de Vries R; Sluiter WJ; van Tol A
    Biochim Biophys Acta; 2010 Jan; 1801(1):84-8. PubMed ID: 19800416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete and Partial Lecithin:Cholesterol Acyltransferase Deficiency Is Differentially Associated With Atherosclerosis.
    Oldoni F; Baldassarre D; Castelnuovo S; Ossoli A; Amato M; van Capelleveen J; Hovingh GK; De Groot E; Bochem A; Simonelli S; Barbieri S; Veglia F; Franceschini G; Kuivenhoven JA; Holleboom AG; Calabresi L
    Circulation; 2018 Sep; 138(10):1000-1007. PubMed ID: 29748187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and environmental determinants of plasma high density lipoprotein cholesterol and apolipoprotein AI concentrations in healthy middle-aged men.
    Talmud PJ; Hawe E; Robertson K; Miller GJ; Miller NE; Humphries SE
    Ann Hum Genet; 2002 Mar; 66(Pt 2):111-24. PubMed ID: 12174215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with low HDL-cholesterol caused by mutations in LCAT have increased arterial stiffness.
    van den Bogaard B; Holleboom AG; Duivenvoorden R; Hutten BA; Kastelein JJ; Hovingh GK; Kuivenhoven JA; Stroes ES; van den Born BJ
    Atherosclerosis; 2012 Dec; 225(2):481-5. PubMed ID: 23078883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel protein glycan biomarker and LCAT activity in metabolic syndrome.
    Gruppen EG; Connelly MA; Otvos JD; Bakker SJ; Dullaart RP
    Eur J Clin Invest; 2015 Aug; 45(8):850-9. PubMed ID: 26081900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.